| Pharmaceutical Information |
| Drug Name |
Trimethadione |
| Drug ID |
BADD_D02287 |
| Description |
An anticonvulsant effective in absence seizures, but generally reserved for refractory cases because of its toxicity. (From AMA Drug Evaluations Annual, 1994, p378) |
| Indications and Usage |
Used in the control of absence (petit mal) seizures that are refractory to treatment with other medications. |
| Marketing Status |
Prescription; Discontinued |
| ATC Code |
N03AC02 |
| DrugBank ID |
DB00347
|
| KEGG ID |
D00392
|
| MeSH ID |
D014293
|
| PubChem ID |
5576
|
| TTD Drug ID |
D0U4VT
|
| NDC Product Code |
43798-500 |
| Synonyms |
Trimethadione | Troxidone | Tridione | Trimetin |
|
| Chemical Information |
| Molecular Formula |
C6H9NO3 |
| CAS Registry Number |
127-48-0 |
| SMILES |
CC1(C(=O)N(C(=O)O1)C)C |
| Chemical Structure |
|
|
| ADRs Induced by Drug |
|
| ADR Term |
ADReCS ID |
ADR Frequency (FAERS)
|
ADR Severity Grade (FAERS)
|
ADR Severity Grade (CTCAE)
|
| Ill-defined disorder | 08.01.03.049 | - | - | Not Available |
|
|
|
